Results 31 to 40 of about 1,518,675 (340)
Health & Justice, 2023 Background The COVID-19 pandemic has disproportionately impacted individuals in carceral facilities – both incarcerated people and staff. Vaccination is an important tool in reducing the risk of COVID-19 infection, hospitalization, and death.
Ingie Osman +4 more
doaj +1 more source
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
New England Journal of Medicine, 2021 Background Despite high vaccine coverage and effectiveness, the incidence of symptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been increasing in Israel.
Einav G. Levin +13 more
semanticscholar +1 more source
COVID‐19 vaccine‐associated organizing pneumonia
Respirology Case Reports, 2022 We report the first case of organizing pneumonia (OP) associated with a new coronavirus disease (COVID‐19) vaccination. A 78‐year‐old woman developed cough and dyspnoea 10 days after receiving BNT162b2.
Tomohiro Yoshikawa +7 more
doaj +1 more source
Covid-19 Vaccine Acceptance and Determinants– An Online Cross-Sectional Survey in Kerala, India
National Journal of Community Medicine, 2021 Background: Covid-19 vaccination threshold is key to pandemic control. This study aimed to assess the Covid-19 vaccine acceptance and determinants at Kerala, India. Methods: A cross-sectional web- based study was conducted in Kerala, India from April-
Pratibha Dabas +5 more
doaj +1 more source
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
New England Journal of Medicine, 2020 Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide.
E. Walsh +24 more
semanticscholar +1 more source
Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination
Circulation Research, 2022 The risk of stroke and cerebrovascular disease complicating infection with SARS-CoV-2 has been extensively reported since the onset of the pandemic. The striking efforts of many scientists in cooperation with regulators and governments worldwide have rapidly brought the development of a large landscape of vaccines against SARS-CoV-2.
Manuela De Michele +6 more
openaire +3 more sources
Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States
Frontiers in Immunology, 2021 The arrival of the COVID-19 vaccine has been accompanied by increased discussion of vaccine hesitancy. However, it is unclear if there are shared patterns between general vaccine hesitancy and COVID-19 vaccine rejection, or if these are two different ...
Shu-Fang Shih +7 more
doaj +1 more source
The Lancet, 2021 Background Vaccine effectiveness studies have not differentiated the effect of the delta (B.1.617.2) variant and potential waning immunity in observed reductions in effectiveness against SARS-CoV-2 infections.
S. Tartof +14 more
semanticscholar +1 more source
BARRIER PERCEPTION FACTORS AFFECTING THE ACCEPTANCE OF THE COVID-19 VACCINE IN SALATIGA CITY
Jurnal Berkala Epidemiologi, 2023 Background: In Salatiga City, COVID-19 immunization still needs to meet the 70% vaccination target needed to generate herd immunity. Vaccine skepticism and injection phobia can be barriers.
Lu'luil Ma'rifati +2 more
doaj +1 more source
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
New England Journal of Medicine, 2021 Background Efficacious vaccines are urgently needed to contain the ongoing coronavirus disease 2019 (Covid-19) pandemic of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
J. Sadoff +26 more
semanticscholar +1 more source